Integral Derivatives’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,594
Closed -$2.26M 1347
2017
Q3
$2.58M Buy
12,594
+7,590
+152% +$1.77M 0.05% 255
2017
Q2
$1.22M Buy
+5,004
New +$1.18M 0.03% 425
2017
Q1
Sell
-41,025
Closed -$9.55M 1449
2016
Q4
$8.62M Buy
41,025
+27,218
+197% +$5.64M 0.16% 76
2016
Q3
$3.18M Sell
13,807
-7,252
-34% -$1.77M 0.07% 178
2016
Q2
$4.87M Buy
21,059
+12,537
+147% +$2.89M 0.12% 111
2016
Q1
$2.28M Sell
8,522
-6,135
-42% -$1.76M 0.07% 190
2015
Q4
$4.58M Buy
14,657
+1,943
+15% +$578K 0.12% 138
2015
Q3
$3.46M Buy
12,714
+7,601
+149% +$2.33M 0.09% 179
2015
Q2
$1.55M Sell
5,113
-876
-15% -$261K 0.04% 395
2015
Q1
$1.78M Sell
5,989
-4,725
-44% -$1.35M 0.04% 314
2014
Q4
$2.76M Sell
10,714
-4,352
-29% -$1.09M 0.05% 327
2014
Q3
$3.63M Buy
15,066
+8,612
+133% +$1.93M 0.06% 270
2014
Q2
$1.44M Sell
6,454
-3,109
-33% -$644K 0.03% 546
2014
Q1
$1.97M Buy
9,563
+1,910
+25% +$378K 0.04% 415
2013
Q4
$1.29M Buy
+7,653
New +$1.2M 0.02% 692

Other funds holding AGN

Integral Derivatives's AGN Position: Q4 2017 in Review

Integral Derivatives sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 12,594 shares — an estimated $2.26M sold.

Integral Derivatives first reported a position in AGN in Q4 2013 and held it in 15 quarters. The position peaked at $8.62M in Q4 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Integral Derivatives reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 12,594 Allergan plc shares in Q4 2017, an estimated $2.26M.
  • Integral Derivatives first reported a position in Allergan plc in Q4 2013 and held it in 15 quarters.
  • Integral Derivatives's Allergan plc position peaked at $8.62M in Q4 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.